TB Alternative Assets Ltd. 13D and 13G filings for Molecular Data Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-08 06:12 am Purchase |
2019-12-06 | 13G | Molecular Data Inc. MKD |
TB Alternative Assets Ltd. | 20,044,756 4.840% |
18,762,624 (+1463.39%) |
Filing |
| 2022-02-11 07:00 am Sale |
2019-12-06 | 13G | Molecular Data Inc. MKD |
TB Alternative Assets Ltd. | 1,282,132 4.640% |
-423,242 (-24.82%) |
Filing |
| 2022-02-11 06:54 am Purchase |
2019-12-06 | 13G | Molecular Data Inc. MKD |
TB Alternative Assets Ltd. | 1,705,375 6.180% |
152,299 (+9.81%) |
Filing |
| 2021-02-16 06:29 am Sale |
2019-12-06 | 13G | Molecular Data Inc. MKD |
TB Alternative Assets Ltd. | 1,553,075 6.750% |
-423,242 (-21.42%) |
Filing |
| 2021-02-16 06:26 am Purchase |
2019-12-06 | 13G | Molecular Data Inc. MKD |
TB Alternative Assets Ltd. | 1,976,318 8.590% |
1,976,318 (New Position) |
Filing |